CRIS Current Research Information System

ZUFFA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.632
EU - Europa 1.356
AS - Asia 1.195
AF - Africa 95
SA - Sud America 58
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 4.342
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.611
GB - Regno Unito 355
SG - Singapore 354
CN - Cina 340
VN - Vietnam 291
SE - Svezia 213
DE - Germania 192
IT - Italia 150
HK - Hong Kong 79
UA - Ucraina 78
FR - Francia 68
RU - Federazione Russa 67
NL - Olanda 62
IN - India 61
IE - Irlanda 51
BR - Brasile 40
TG - Togo 30
EE - Estonia 27
ZA - Sudafrica 26
FI - Finlandia 24
NG - Nigeria 22
JP - Giappone 18
CA - Canada 17
BG - Bulgaria 14
JO - Giordania 14
BE - Belgio 12
KR - Corea 11
CI - Costa d'Avorio 10
AR - Argentina 9
PL - Polonia 8
CH - Svizzera 7
AT - Austria 5
HR - Croazia 5
PY - Paraguay 5
SC - Seychelles 5
ES - Italia 4
GR - Grecia 4
ID - Indonesia 4
IQ - Iraq 4
IR - Iran 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
EU - Europa 3
RO - Romania 3
TR - Turchia 3
BD - Bangladesh 2
LT - Lituania 2
LV - Lettonia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
TN - Tunisia 1
Totale 4.342
Salva come PNG Salva come JPEG
Città #
Southend 322
Singapore 259
Dong Ket 201
Ashburn 197
Chandler 179
Fairfield 117
Ann Arbor 92
Hong Kong 78
Seattle 73
Wilmington 73
Beijing 71
Houston 67
Woodbridge 66
Princeton 58
Dublin 51
Jacksonville 47
Boardman 45
Cambridge 42
Santa Clara 42
New York 37
Lomé 30
Padova 30
Westminster 29
Hefei 28
Nanjing 26
Bologna 24
Los Angeles 24
Medford 22
Munich 20
Berlin 19
Ho Chi Minh City 19
Jinan 18
Abeokuta 17
Hanoi 17
Helsinki 17
Tokyo 17
Milan 15
Amman 14
Sofia 14
Changsha 13
Frankfurt am Main 13
Saint Petersburg 13
Brussels 12
Seoul 11
Abidjan 10
Bremen 10
Redondo Beach 10
Toronto 10
Hebei 9
Falkenstein 8
Guangzhou 7
Jiaxing 7
Redwood City 7
Shenyang 7
Buffalo 6
Falls Church 6
Nanchang 6
Paris 6
Romainville 6
Shanghai 6
São Paulo 6
Turin 6
Turku 6
Bühl 5
Hangzhou 5
Mountain View 5
Mülheim 5
San Diego 5
Bern 4
Brooklyn 4
Chengdu 4
Dearborn 4
Düsseldorf 4
Lauterbourg 4
Norwalk 4
Rome 4
Stockholm 4
Tianjin 4
Verona 4
Wroclaw 4
Xi'an 4
Zhengzhou 4
Andover 3
Atlanta 3
Baghdad 3
Bengaluru 3
Chicago 3
Dallas 3
Florence 3
Fuzhou 3
Hải Dương 3
Kunming 3
Leawood 3
Mahé 3
Ningbo 3
Nuremberg 3
Shijiazhuang 3
Taizhou 3
Vienna 3
Winnipeg 3
Totale 2.853
Salva come PNG Salva come JPEG
Nome #
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 257
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 210
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 208
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 203
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 199
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities 183
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 167
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 166
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 162
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 162
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 158
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 152
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 152
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 151
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 148
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 146
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 145
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 138
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 133
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 125
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 124
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma. 121
Evaluation of the Diasorin Q-Lamp technology for the molecular diagnosis of the philadelphia positive leukemias: an italian multicenter study 121
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 120
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 120
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 117
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 112
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 108
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 108
Totale 4.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 27 22 26 38 25 33 279
2021/2022592 31 15 36 66 55 32 16 26 27 41 124 123
2022/2023710 98 97 47 90 50 58 15 35 116 22 50 32
2023/2024193 4 31 5 34 14 53 14 9 7 8 7 7
2024/2025648 11 102 57 51 75 23 67 27 6 84 18 127
2025/2026688 141 92 111 91 248 5 0 0 0 0 0 0
Totale 4.416